Skip to main content

Clinical Experience with Spinal Morphine, Midazolam and Tizanidine in Spasticity

  • Conference paper

Abstract

The starting point for systemic pharmacological treatment of spasticity was mephenesin, introduced in 1946. Although often stated to depress reflex activity by blocking spinal interneurons without affecting muscular function, mephenesin had a paralyzing effect in experimental animals and in man [2]. It was more or less by chance that mephenesin was also the first non-neurolytic drug to be administered intrathecally in patients with spasticity. According to these investigations intrathecal mephenesin was considered to be a potential alternative to intrathecal phenol or alcohol [10].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Atweh SF, Kuhar MJ (1977) Autoradiographic localisation of opiate receptors in rat brain, spinal cord and lower medulla. Brain Res 124:53–67

    Article  PubMed  CAS  Google Scholar 

  2. Berger FM, Bradley W (1946) The pharmacological properties of a β-dihydroxy-gamma (2-methylphenoxy)-propane (Myanesin). Br J Pharmacol 1:265–272

    CAS  Google Scholar 

  3. Biggio D, Dell Bella D, Frigeni V, Guidotti A (1977) Potentiation of morphine analgesia by muscimol. Neuropharmacology 16:149–150

    Article  PubMed  CAS  Google Scholar 

  4. Cahusac PM, Evans RH, Hill RG, Rodriquez RE, Smith DA (1984) The behavioural effects of N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology 23:719–724

    Article  PubMed  CAS  Google Scholar 

  5. Carrasco MS, Torres LM, Requena LM, Martin ML, Garcia de Sola R (1985) Accion analgesica del midazolam administrado intraduralmente en el perro. Rev Esp Anestesiol Reanim 32:96–100

    PubMed  CAS  Google Scholar 

  6. Contreras E, Tamayo L, Quijada L (1979) Effects of irreversible inhibition of GABA transaminase upon some morphine effects. Neuropharmacology 29:1002–1005

    Google Scholar 

  7. Cook JB, Nathan PW (1967) On the site of action of diazepam in spasticity in man. J Neurol Sci 5:33–37

    Article  PubMed  CAS  Google Scholar 

  8. Davies J (1978) Études électrophysiologiques des opiacés et des peptides endogènes sur les neurones centreaux. Ann Anesth Franc 19:399–403

    CAS  Google Scholar 

  9. De Castro J (1976) Sequential analgesic anesthesia: basic considerations. Anesth Réan Prat 7:9

    Google Scholar 

  10. Delaney JF (1980) Medical treatment of spasticity. Curr Probi Surg 17:245–248

    Article  CAS  Google Scholar 

  11. Dell EE (1975) Naloxon-reversal of diazepam sedation in children. Pediatrics 87:803–807

    Article  Google Scholar 

  12. Duggan AW, Curtis DR (1972) Morphine and the synaptic activation of Renshaw cells. Neuropharmacology 11:189–193

    Article  PubMed  CAS  Google Scholar 

  13. Erickson DL, Blacklock JB, Michaelson M, Sperling KB, Lo JN (1985) Control of spasticity by implantable continuous flow morphine pump. Neurosurgery 16:215–217

    Article  PubMed  CAS  Google Scholar 

  14. Fowlks EW, Strickland DA, Peirson GA (1965) Control of spastic states in neurologic patients with diazepam. Am J Phys Med 44: 9–15

    PubMed  CAS  Google Scholar 

  15. Fragen RJ, Gahl F, Cadwell N (1978) A water-soluble benzodiazepine, Ro 21-3981, for induction of anesthesia. Anesthesiology 49:41–46

    Article  PubMed  CAS  Google Scholar 

  16. Gallager DW (1982) Benzodiazepines and gamma-aminobutyric acid. Sleep 5:3–14

    Google Scholar 

  17. Gerstenbrand F, Lörincz A, Ludin HP, Ringwald E (1979) Langzeitbehandlung mit dem Imidazolinderivat DS 103-282. Nervenarzt 50:806–808

    PubMed  CAS  Google Scholar 

  18. Hunt SP, Kelly JS, Emson PC (1980) The electromicroscope localization of methionine-enkephalin within the superficial layers (I and II) of the spinal cord. Neuroscience 5:1871–1874

    Article  PubMed  CAS  Google Scholar 

  19. Jellinger K (1984) Zur Behandlung der Spastizität bei multipler Sklerose. Ergebnisse einer Doppelblindstudie mit Tizanidin und Diazepam. In: Conrad B, Benecke R, Bauer HJ (eds) Die klinische Wertung der Spastizität. Schattauer, Stuttgart New York

    Google Scholar 

  20. Jurna I (1984) Depression of nociceptive sensory activity in the rat spinal cord due to the intrathecal administration of drugs: effect of diazepam. Neurosurgery 15:917–920

    Article  PubMed  CAS  Google Scholar 

  21. Knutsson E, Mårtensson A, Gransberg L (1982) Antiparetic and antispastic effects induced by tizanidine in patients with spastic paresis. J Neurol Sci 53:187–204

    Article  PubMed  CAS  Google Scholar 

  22. Kuster J (1972) Increased creatine-kinase concentrations after intramuscular injection of diazepam. German Med 2:154–155

    Google Scholar 

  23. Langdon DE, Harlan JR, Bailey RJ (1973) Thrombophlebitis with diazepam used intravenously. JAMA 223:184–186

    Article  PubMed  CAS  Google Scholar 

  24. Levine IM, Jossmann PB, Friend DG, De-Angelis V, Kane M (1969) Diazepam in the treatment of spasticity. J Chronic Dis 22:57–65

    Article  Google Scholar 

  25. Lo JN, Erickson DL (1984) Relief of post-spinal trauma spasticity with intrathecal morphine. Anesthesiology 61: A 220

    Google Scholar 

  26. Mackel R, Brink EE, Nakajima A (1984) Action of tizanidine on responses of forearm flexors and extensors to the torque disturbances. J Neurol Neurosurg Psychiatry 47:1109–1116

    Article  PubMed  CAS  Google Scholar 

  27. Müller H, Aigner K, Zierski J (1985) Behandlung von Tumorschmerz mit Pumpsystemen zur rückenmarksnahen Opiatapplikation. Dtsch Ärzteblatt 35:2475–2484

    Google Scholar 

  28. Müller H, Schleussner E, Stoyanov M, Kling D, Hempelmann G (1981) Haemodynamic effects and characteristics of midazolam during induction of anaesthesia. Drug Res 31:2227–2231

    Google Scholar 

  29. Newman PM, Nogues M, Newman PK, Weightman D, Hudgson P (1982) Tizanidine in the treatment of spasticity. Eur J Clin Pharmacol 23:31–35

    Article  PubMed  CAS  Google Scholar 

  30. Nicoli RA, Alger BE, Hahr CE (1980) Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature 287:22–27

    Article  Google Scholar 

  31. Niv D, Whitwam JG, Loh L (1983) Depression of nociceptive sympathetic reflexes by the intrathecal administration of midazolam. Br J Anaesth 55:541–547

    Article  PubMed  CAS  Google Scholar 

  32. Pieri L, Schaffner R, Scherschlicht R, Polc P, Sepinwall J, Davidson A, Möhler H, Cumin R, Da Prada M, Burkard WP, Keller HH, Müller RKM, Gerold M, Pieri M, Cook L, Haefely W (1981) Pharmacology of midazolam. Drug Res 31:2180–2190

    CAS  Google Scholar 

  33. Pierson GA, Fowlks EW, King PS (1968) Long-term follow-up of the use of diazepam in the treatment of spasticity. Am J Phys Med 47:143–148

    Google Scholar 

  34. Pomeranz B, Gurevich N (1979) Effects of enkephalin analogues and naloxone on cat spinal cord dorsal root potentials. Eur J Pharmacol 60:307–311

    Article  PubMed  CAS  Google Scholar 

  35. Rigoli M (1982) A water-soluble benzodiazepine (midazolam) used by the epidural route for acute and chronic pain. 2nd International postgraduate practical course on pain therapy, 20. 9.-2. 10. 1982, Vicenza (Italy)

    Google Scholar 

  36. Rigoli M (1983) Epidural analgesia with benzodiazepines. In: Tiengo M, Cousins MJ (eds) Pharmacological basis of anesthesiology: clinical pharmacology of new analgesics and anesthetics. Raven Press, New York, pp 69–76

    Google Scholar 

  37. Ringwald E, Campean SJ, Gerstenbrand F, Lörincz P, Ludin HP (1977) Klinische Erfahrungen mit einem neurartigen Myotonolytikum (DS 102-282 Sandoz). Nervenarzt 48:355–358

    PubMed  CAS  Google Scholar 

  38. Rinne UK (1980) Tizanidine treatment of spasticity in multiple sclerosis and chronic myelopathy. Curr Ther Res 28:827–836

    Google Scholar 

  39. Sayers AC, Burchi HR, Eichenberger E (1980) The pharmacology of DS 103-382, a novel myotonolytic agent. Drug Res 30:793–803

    CAS  Google Scholar 

  40. Squires RF, Braestrup C (1977) Benzodiazepine receptors in rat brain. Nature 266:732–742

    Article  PubMed  CAS  Google Scholar 

  41. Struppler A (1983) Epidural morphine in spasticity (case report). Congress “Endorphines — neurohormones and transmitters”, 20. 9. 1983, Garmisch-Partenkirchen, FRG

    Google Scholar 

  42. Turski L, Klockgether T, Schwarz M, Turski WA, Sontag KH (1986) Spinal cord: a site of muscle relaxant action of excitatory amino acid antagonists. In: Roberts PJ, Storm-Mathisen J, Bradford HF (eds) Excitatory amino acids. Macmillan, London, pp 459–461

    Google Scholar 

  43. Turski L, Klockgether T, Sontag KH, Herrling PL, Watkins JC (1987) Muscle relaxant and anticonvulsant activity of 3-((±)-2-carboxypiperazin-2-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents. Neurosci Lett 73:143–148

    Article  PubMed  CAS  Google Scholar 

  44. Whitwam JG, Niv D, Loh L, Jack RD (1982) Depression of nociceptive reflexes by intrathecal benzodiazepine in dogs. Lancet II:1465

    Article  Google Scholar 

  45. Wilson LA (1970) The management of spasticity and rigidity using parenteral diazepam. Gerontol Clin 12:168–176

    Article  CAS  Google Scholar 

  46. Wilson LA, McKechnie AA (1966) Oral diazepam in the treatment of spasticity in paraplegia: a double-blind trial and subsequent impression. Scott Med J 11:46–51

    PubMed  CAS  Google Scholar 

  47. Wikler A (1950) Sites and mechanisms of action of morphine and related drugs in the central nervous system. Pharmacol Rev 2: 435–506

    Google Scholar 

  48. Yaksh TL (1981) Spinal opiate analgesia: characteristics and principles of action. Pain 11:293–346

    Article  PubMed  CAS  Google Scholar 

  49. Yaksh TL, Müller H (ed) (1982) Spinal opiate analgesia. Experimental and clinical studies. Springer, Berlin Heidelberg New York

    Google Scholar 

  50. Yoneda T, Takashima S, Kuriyama K (1976) Possible involvement of GABA in morphine analgesia. Biochem Pharmacol 25:2669–2670

    Article  PubMed  CAS  Google Scholar 

  51. Zieglgänsberger W, Bayerl H (1976) The mechanism of inhibition of neuronal activity by opiates in the spinal cord of cat. Brain Res 115:111–128

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Müller, H., Zierski, J. (1988). Clinical Experience with Spinal Morphine, Midazolam and Tizanidine in Spasticity. In: Müller, H., Zierski, J., Penn, R.D. (eds) Local-spinal Therapy of Spasticity. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72954-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72954-6_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-18295-5

  • Online ISBN: 978-3-642-72954-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics